Contemporary Management of Recurrent Nodal Disease in Differentiated Thyroid Carcinoma

Differentiated thyroid carcinoma (DTC) comprises over 90% of thyroid tumors and includes papillary and follicular carcinomas. Patients with DTC have an excellent prognosis, with a 10-year survival rate of over 90%. However, the risk of recurrent tumor ranges between 5% and 30% within 10 years of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Na’ara, Shorook, Amit, Moran, Fridman, Eran, Gil, Ziv
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Rambam Health Care Campus 2016
Materias:
Special Issue on Differentiated Thyroid Carcinoma
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737512/
https://www.ncbi.nlm.nih.gov/pubmed/26886954
http://dx.doi.org/10.5041/RMMJ.10233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737512/
https://www.ncbi.nlm.nih.gov/pubmed/26886954
http://dx.doi.org/10.5041/RMMJ.10233

Ejemplares similares